Breast Cancer Research | Volume 3 Issue 6

official impact factor

5.79

Advanced search

Submit a manuscript Register Follow us on

Explore journal

Articles

	Volume 3 Issue 6
	Comment
	Commentary Wnt signaling in breast cancer: have we come full circle? Anthony MC Brown Breast Cancer Res 2001, 3:351-355 (6 September 2001) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Commentary PTEN deficiency: a role in mammary carcinogenesis Teresa Petrocelli, Joyce M Slingerland Breast Cancer Res 2001, 3:356-360 (1 October 2001) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Commentary Predictive factor for the response to adjuvant therapy with emphasis in breast cancer Pamela N Munster, Larry Norton Breast Cancer Res 2001, 3:361-364 (1 October 2001) Abstract \| Full text \| PDF \| PubMed
	Review
	Review Tumour-stromal interactions: Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland Sandra Z Haslam, Terry L Woodward Breast Cancer Res 2001, 3:365-372 (2 August 2001) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Review Tumour-stromal interactions: Phenotypic and genetic alterations in mammary stroma - implications for tumour progression Seth L Schor, Ana M Schor Breast Cancer Res 2001, 3:373-379 (6 September 2001) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Review Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition Isabel Correa, Tim Plunkett Breast Cancer Res 2001, 3:399-403 (20 September 2001) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Review Update on HER-2 as a target for cancer therapy: Alternative strategies for targeting the epidermal growth factor system in cancer William J Gullick Breast Cancer Res 2001, 3:390-394 (1 October 2001) Abstract \| Full text \| PDF \| PubMed
	Review Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment Helen C Hurst Breast Cancer Res 2001, 3:395-398 (1 October 2001) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Review Intracellular signaling pathways of ErbB2/HER-2 and family members Monilola A Olayioye Breast Cancer Res 2001, 3:385-389 (4 October 2001) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Review Update on HER-2 as a target for cancer therapy: Herceptin in the clinical setting David W Miles Breast Cancer Res 2001, 3:380-384 (11 October 2001) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Report
	Meeting report Reasons for Hope: Canadian Breast Cancer Research Conference, Le Concorde Hotel, Quebec City, Quebec, Canada, 3–5 May 2001 Calvin Roskelley Breast Cancer Res 2001, 3:404-406 (10 August 2001) Abstract \| Full text \| PDF \| PubMed
	Research
	Research article Investigation of glutathione S-transferase zeta and the development of sporadic breast cancer Robert A Smith, Joanne E Curran, Stephen R Weinstein, Lyn R Griffiths Breast Cancer Res 2001, 3:409-411 (10 October 2001) Abstract \| Full text \| PDF \| PubMed